Langogo Medical Lands ￥10M Series Pre-A Funding

(VCBeat) Mar. 10, 2021 -- Shanghai Langogo Medical Technology Co., Ltd. ("Langogo Medical") announced today that it has raised tens of millions of yuan in the Series Pre-A financing. The funds raised are earmarked for Blue Regale's product R&D, factory construction, equipment improvement, and sales channel building. This round of financing is co-invested by Taiyu Ankang and related industrial funds, with Chana Capital serving as the financial adviser.

Langogo Medical focuses on the scientific research, production and sales of formula food for special medical purposes and top innovative nutrition products in the world. It is an innovative technology enterprise integrating professional nutrition diagnosis and service.

Langogo Medical is committed to providing high-quality and professional nutritional support for patients or special groups, helping patients and those groups recover and improve the quality of life.

Langogo Medical has strong teams, including a food and nutrition R&D team headed by Ms. Zhu Beiwei, an academician of the Chinese Academy of Engineering, a high-level production and quality management team, and a clinical nutrition and healthy food research institute. At the same time, the company has reached in-depth cooperation with Jiangnan University, West China Hospital, Xijing Hospital and Shanghai International Medical Center to carry out clinical researches and build a transformation base for production, education and research.

In terms of R&D facilities, Langogo Medical has two special medical food production bases in Qingdao and Kunshan, which consists of high-tech and intelligent production workshops and laboratories with full nutrition testing ability in line with the international standard.

Langogo Medical has a comprehensive product matrix with distinctive features in the special medical food sector. The application for certification of several products is proceeding smoothly.

Relying on the listed company Tigermed and founded by Taiyu Capital, Tigermed’s subsidiary with medical background and professional experience in equity investment, and Ankang Healthcare, a leading CRO with international vision and practical experience in the field of health food, Taiyu Ankang focuses on investments in early and growth stage in the field of nutrition and health.